PH25728A - Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type - Google Patents

Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type

Info

Publication number
PH25728A
PH25728A PH37078A PH37078A PH25728A PH 25728 A PH25728 A PH 25728A PH 37078 A PH37078 A PH 37078A PH 37078 A PH37078 A PH 37078A PH 25728 A PH25728 A PH 25728A
Authority
PH
Philippines
Prior art keywords
antigestagen
trilostane
synthesis inhibitor
progesteron
combined use
Prior art date
Application number
PH37078A
Inventor
Walter Dr Elger
Sybille Dr Beir
Beate Kosub
Marrianne Fanrich
Of Dr Krzysztof Dr Chwalisz
Gordon Dr Oliver
Original Assignee
Schering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering filed Critical Schering
Publication of PH25728A publication Critical patent/PH25728A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The medicine contains a progesterone synthesis inhibitor (ProH) of the trilostane or epostane type and an antigestagen (AG) and is used for inducing labour at term in humans and animals and for terminating normal or pathological pregnancy. The combination according to the invention is also suitable for treating hormone-dependent tumours, endometriosis and dysmenorrhoea.
PH37078A 1987-06-16 1988-06-15 Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type PH25728A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720420 DE3720420A1 (en) 1987-06-16 1987-06-16 PROGESTERONE SYNTHESIS INHIBITOR AND ANTI-STAGE TO BEGINNING BIRTH OR FOR PREGNANCY

Publications (1)

Publication Number Publication Date
PH25728A true PH25728A (en) 1991-10-18

Family

ID=6329981

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37078A PH25728A (en) 1987-06-16 1988-06-15 Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type

Country Status (12)

Country Link
EP (1) EP0296097B1 (en)
JP (1) JP2716461B2 (en)
AT (1) ATE94391T1 (en)
AU (1) AU611160B2 (en)
CA (1) CA1318251C (en)
DE (2) DE3720420A1 (en)
DK (1) DK327288A (en)
ES (1) ES2059556T3 (en)
IE (1) IE63453B1 (en)
IL (1) IL86731A (en)
PH (1) PH25728A (en)
ZA (1) ZA884315B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645697A (en) * 1992-09-25 1997-07-08 Middleton; David Leslie Phillip Preventing contaminant build-up in beer lines
GB2345851B (en) * 2000-01-18 2004-05-26 Gavin Paul Vinson A combination of trilostane or keto-trilostane and an anti-oestrogen for the treatment of an oestrogen-dependent cancer or tumour

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062954A (en) * 1976-12-27 1977-12-13 Sterling Drug Inc. Process for using a steroid compound
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity

Also Published As

Publication number Publication date
IE881804L (en) 1988-12-16
DE3720420A1 (en) 1988-12-29
JPS63316725A (en) 1988-12-26
EP0296097B1 (en) 1993-09-15
DE3884067D1 (en) 1993-10-21
IL86731A (en) 1992-11-15
ZA884315B (en) 1989-06-28
ES2059556T3 (en) 1994-11-16
IE63453B1 (en) 1995-04-19
AU1775088A (en) 1988-12-22
EP0296097A2 (en) 1988-12-21
CA1318251C (en) 1993-05-25
EP0296097A3 (en) 1990-04-04
DK327288D0 (en) 1988-06-15
ATE94391T1 (en) 1993-10-15
AU611160B2 (en) 1991-06-06
IL86731A0 (en) 1988-11-30
DK327288A (en) 1988-12-17
JP2716461B2 (en) 1998-02-18

Similar Documents

Publication Publication Date Title
Popovich et al. The maxillary interincisal diastema and its relationship to the superior labial frenum and intermaxillary suture
EP0236684A3 (en) Galanthamine or analogues thereof for treating alzheimer's disease
NZ256681A (en) Tablet containing ranitidine (or its salt), chewable base, and flavouring; the tablet is free of alginic acid with sodium bicarbonate
JPS5413651A (en) House ventilating device
PH25728A (en) Combined use of an antigestagen, a progesteron synthesis inhibitor of the trilostane, epostane type
ZA857721B (en) Process for treatment of rheumatic diseases
JPS5431952A (en) Temperature controller
NO883743D0 (en) PROCEDURE AND DEVICE FOR AA GIVING PERSONAL AIR CONDITION ("AIR CONDITION").
JPS51113435A (en) Offering processor
JPS52149433A (en) Electronic computer system running system
JPS51141279A (en) Method of improving physical constitution of cattle
EP0151385A3 (en) Use of phytosterolglycosides for the treatment of elevated 5(6) alpha-epoxycholesterol levels
ES451701A1 (en) 6{62 ,17-Dihydroxy-7{60 -(lower alkoxy)carbonyl-3-oxo-17{60 -pregn-4-ene-21-carboxylic acid {65 -lactones and congeners
AU6461590A (en)
NZ220242A (en) Regulating fertility in cattle by administering epostane
JPS51150940A (en) Cashless card and cashless system
JPS5413648A (en) Indoor temperature controller system
JPS5419069A (en) Hydraulic driving apparatus
Jamail The impostor phenomenon and high-achieving men and women issues of sex and self-perceived atypicality.
JPS5235017A (en) Train control system
Burchett Race and the AWOL offender: the effect of the defendant's race on the outcome on courts-martial involving absence without leave.
JPS53110440A (en) Prevention system for competition between processors
Gallagher The hubris of philosophy: Alcibiades' praise of Socrates in Plato's Symposium
Ames The comparison of femoral fracture repair in young calves
JPS53129700A (en) Automatic ticket examination apparatus